Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Purchase
Voting Common Shares, no par value per share
2023-06-23$3.91/sh+12,787$49,997→ 68,591 total
Footnotes (1)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.